Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Seitz JF

Collect these papers and discover other ones on Labmeeting. Learn more.

Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.

+ cite this

+ View Abstract

Poincloux L, Durando X, Seitz JF, Thivat E, Bardou VJ, Giovannini MH, Parriaux D, Barriere N, Giovannini M, Delpero JR, and Monges G

Surgical oncology 18(4):357-65, 2009 Dec - Who cited this? | PubMed ID: 19027288 | Fulltext

Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines.

+ cite this

+ View Abstract

Dahan L, Sadok A, Formento JL, Seitz JF, and Kovacic H

British journal of pharmacology 158(2):610-20, 2009 Sep - Who cited this? | PubMed ID: 19732064 | Fulltext

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).

+ cite this

+ View Abstract

Ychou M, Raoul JL, Douillard JY, Gourgou-Bourgade S, Bugat R, Mineur L, Viret F, Becouarn Y, Bouché O, Gamelin E, Ducreux M, Conroy T, Seitz JF, Bedenne L, and Kramar A

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 20(4):674-80, 2009 Apr - Who cited this? | PubMed ID: 19179549 | Fulltext

Extracapsular lymph node involvement is a negative prognostic factor after neoadjuvant chemoradiotherapy in locally advanced esophageal cancer.

+ cite this

+ View Abstract

D'Journo XB, Avaro JP, Michelet P, Trousse D, Tasei AM, Dahan L, Doddoli C, Guidicelli R, Fuentes P, Seitz JF, and Thomas P

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 4(4):534-9, 2009 Apr - Who cited this? | PubMed ID: 19347985 | Fulltext

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

+ cite this

+ View Abstract

Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, Zheng Y, Green E, Labianca R, O'Callaghan C, Seitz JF, Francini G, Haller D, Yothers G, Goldberg R, and de Gramont A

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(6):872-7, 2009 Feb 20 - Who cited this? | PubMed ID: 19124803 | Fulltext

Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France.

+ cite this

+ View Abstract

Lombard-Bohas C, Mitry E, O'Toole D, Louvet C, Pillon D, Cadiot G, Borson-Chazot F, Aparicio T, Ducreux M, Lecomte T, Etienne PL, Cacheux W, Legoux JL, Seitz JF, Ruszniewski P, Chayvialle JA,

(show remaining authors)

Neuroendocrinology 89(2):217-22, 2009 - Who cited this? | PubMed ID: 18719344 | Fulltext

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer.

+ cite this

+ View Abstract

Conroy T, Viret F, François E, Seitz JF, Boige V, Ducreux M, Ychou M, Metges JP, Giovannini M, Yataghene Y, and Peiffert D

British journal of cancer 99(9):1395-401, 2008 Nov 4 - Who cited this? | PubMed ID: 18841161 | Fulltext

Cetuximab with concurrent chemoradiation for esophagogastric cancer: in regard to safran et Al. (Int j radiat oncol biol phys 2008;70:391-395).

+ cite this

Adenis A, Mariette C, Mirabel X, Seitz JF, and Conroy T

International journal of radiation oncology, biology, physics 72(3):958-9, 2008 Nov 1 - Who cited this? | PubMed ID: 19014786 | Fulltext

Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: A retrospective 35-year study of 12 patients.

+ cite this

+ View Abstract

Bégu-Le Corroller A, Valéro R, Moutardier V, Henry JF, Le Treut YP, Gueydan M, De Micco C, Sierra M, Conte-Devolx B, Oliver C, Raccah D, Favre R, Digue L, Heim M, Seitz JF, Delpero JR,

(show remaining authors)

Diabetes & metabolism 34(4):343-8, 2008 Sep - Who cited this? | PubMed ID: 18556231 | Fulltext

K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.

+ cite this

+ View Abstract

Etienne-Grimaldi MC, Formento JL, Francoual M, François E, Formento P, Renée N, Laurent-Puig P, Chazal M, Benchimol D, Delpero JR, Letoublon C, Pezet D, Seitz JF, and Milano G

Clinical cancer research : an official journal of the American Association for Cancer Research 14(15):4830, 2008 Aug 1 - Who cited this? | PubMed ID: 18676755 | Fulltext

Sorafenib in advanced hepatocellular carcinoma.

+ cite this

+ View Abstract

Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR,

(show remaining authors)

The New England journal of medicine 359(4):378, 2008 Jul 24 - Who cited this? | PubMed ID: 18650514 | Fulltext

Predictive factors of the response to chemoradiotherapy in esophageal cancer.

+ cite this

+ View Abstract

Ressiot E, Dahan L, Liprandi A, Giorgi R, Djourno XB, Padovani L, Alibert S, Ries P, Laquière A, Laugier R, Thomas P, and Seitz JF

Gastroenterologie clinique et biologique, 2008 Jun 12 - Who cited this? | PubMed ID: 18555630 | Fulltext

Indications and outcome of salvage surgery for oesophageal cancer.

+ cite this

+ View Abstract

D'Journo XB, Michelet P, Dahan L, Doddoli C, Seitz JF, Giudicelli R, Fuentes PA, and Thomas PA

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 33(6):1117-23, 2008 Jun - Who cited this? | PubMed ID: 18342532 | Fulltext

High Histone Deacetylase 7 (HDAC7) Expression Is Significantly Associated with Adenocarcinomas of the Pancreas.

+ cite this

+ View Abstract

Ouaïssi M, Sielezneff I, Silvestre R, Sastre B, Bernard JP, Lafontaine JS, Payan MJ, Dahan L, Pirrò N, Seitz JF, Mas E, Lombardo D, and Ouaissi A

Annals of surgical oncology, 2008 May 28 - Who cited this? | PubMed ID: 18506539 | Fulltext

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

+ cite this

+ View Abstract

O'Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, André T, Haller DG, and Sargent DJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(14):2336-41, 2008 May 10 - Who cited this? | PubMed ID: 18467725 | Fulltext

Pancreatic cancer and pancreaticoduodenectomy in elderly patient: morbidity and mortality are increased. Is it the real life?.

+ cite this

+ View Abstract

Ouaïssi M, Sielezneff I, Pirrò N, Merad A, Loundou A, Chaix JB, Dahan L, Ries P, Seitz JF, Payan MJ, Consentino B, and Sastre B

Hepato-gastroenterology 55(88):2242-6, 2008 - Who cited this? | PubMed ID: 19260514 | Fulltext

[Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer.].

+ cite this

+ View Abstract

Dahan L, Ressiot E, Cournede A, Ries P, Duluc M, Laquiere A, Laugier R, Braguer D, and Seitz JF

Gastroenterologie clinique et biologique 31(12):1143-5, 2007 Dec - Who cited this? | PubMed ID: 18176375 | Fulltext

Colorectal cancer screening program: cost effectiveness of systematic recall letters.

+ cite this

+ View Abstract

Tifratene K, Eisinger F, Rinaldi Y, Didelot R, and Seitz JF

Gastroenterologie clinique et biologique 31(11):929-33, 2007 Nov - Who cited this? | PubMed ID: 18166880 | Fulltext

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

+ cite this

+ View Abstract

Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Kerr D, Green E,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25(29):4569-74, 2007 Oct 10 - Who cited this? | PubMed ID: 17876008 | Fulltext

Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation.

+ cite this

+ View Abstract

Mercier C, Raynal C, Dahan L, Ortiz A, Evrard A, Dupuis C, Blesius A, Duluc M, Franceschini F, Giacometti S, Salas S, Milano G, Favre R, Seitz JF, and Ciccolini J

Pharmacogenetics and genomics 17(10):841-4, 2007 Oct - Who cited this? | PubMed ID: 17885621 | Fulltext

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

+ cite this

+ View Abstract

Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, and Binquet C

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25(10):1160-8, 2007 Apr 1 - Who cited this? | PubMed ID: 17401004 | Fulltext

Multimodal treatment of oesophageal cancer.

+ cite this

+ View Abstract

Veuillez V, Rougier P, and Seitz JF

Best practice & research. Clinical gastroenterology 21(6):947-63, 2007 - Who cited this? | PubMed ID: 18070697 | Fulltext

Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting.

+ cite this

+ View Abstract

Douillard JY, Tilleul P, Ychou M, Dufour P, Perrocheau G, Seitz JF, Maes P, Lafuma A, and Husseini F

Oncology 72(3-4):248-54, 2007 - Who cited this? | PubMed ID: 18185019 | Fulltext

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

+ cite this

+ View Abstract

Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, and Bedenne L

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24(28):4620, 2006 Oct 1 - Who cited this? | PubMed ID: 17008704 | Fulltext

A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy.

+ cite this

+ View Abstract

Ciccolini J, Mercier C, Evrard A, Dahan L, Boyer JC, Duffaud F, Richard K, Blanquicett C, Milano G, Blesius A, Durand A, Seitz JF, Favre R, and Lacarelle B

Therapeutic drug monitoring 28(5):678-85, 2006 Oct - Who cited this? | PubMed ID: 17038885 | Fulltext

[What changes were made in the National Thesaurus of Gastrointestinal Cancer in 2005?].

+ cite this

Legoux JL, Bedenne L, Seitz JF, Pezet D, Rougier P, Bouché O, Barbare JC, André T, Malka D, Cadiot G, Ruskoné-Foumestraux A, Landi B, Peiffert D, Ducreux M, Louvet C, and Dorval E

Gastroenterologie clinique et biologique 30(10):1191-5, 2006 Oct - Who cited this? | PubMed ID: 17075477 | Fulltext

Esophagus cancer.

+ cite this

Seitz JF, Dahan L, Jacob J, Artru P, Maingon P, Bedenne L, and Triboulet JP

Gastroenterologie clinique et biologique 30 Spec No 2:2S5-2S15, 2006 Sep - Who cited this? | PubMed ID: 17151558 | Fulltext

Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiency.

+ cite this

+ View Abstract

Ciccolini J, Mercier C, Dahan L, Evrard A, Boyer JC, Richard K, Dales JP, Durand A, Milano G, Seitz JF, and Lacarelle B

Cancer chemotherapy and pharmacology 58(2):272-5, 2006 Aug - Who cited this? | PubMed ID: 16292536 | Fulltext

Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.

+ cite this

+ View Abstract

Mornex F, Girard N, Scoazec JY, Bossard N, Ychou M, Smith D, Seitz JF, Valette PJ, Roy P, Rouanet P, Ducreux M, and Partensky C

International journal of radiation oncology, biology, physics 65(5):1471-8, 2006 Aug 1 - Who cited this? | PubMed ID: 16793214 | Fulltext

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer.

+ cite this

+ View Abstract

Bonnetain F, Bouché O, Michel P, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Paillot B, Arveux P, Milan C, and Bedenne L

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 17(5):827-34, 2006 May - Who cited this? | PubMed ID: 16524973 | Fulltext

Oxaliplatin combined with 5-FU in second line treatment of advanced pancreatic adenocarcinoma. Results of a phase II trial.

+ cite this

+ View Abstract

Mitry E, Ducreux M, Ould-Kaci M, Boige V, Seitz JF, Bugat R, Breau JL, Bouché O, Etienne PL, Tigaud JM, Morvan F, Cvitkovic E, and Rougier P

Gastroenterologie clinique et biologique 30(3):357-63, 2006 Mar - Who cited this? | PubMed ID: 16633299 | Fulltext

[Palliative endoscopic treatments for esophageal cancers].

+ cite this

+ View Abstract

Dahan L, Ries P, Laugier R, and Seitz JF

Gastroenterologie clinique et biologique 30(2):253-61, 2006 Feb - Who cited this? | PubMed ID: 16565659 | Fulltext

'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'.

+ cite this

+ View Abstract

Bennouna J, Perrier H, Paillot B, Priou F, Jacob JH, Hebbar M, Bordenave S, Seitz JF, Cvitkovic F, Dorval E, Malek K, Tonelli D, and Douillard JY

British journal of cancer 94(1):69, 2006 Jan 16 - Who cited this? | PubMed ID: 16404362 | Fulltext

Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial).

+ cite this

+ View Abstract

Duffour J, Bouché O, Rougier P, Milan C, Bedenne L, Seitz JF, Buecher B, Legoux JL, Ducreux M, Vetter D, Raoul JL, François E, and Ychou M

Anticancer research 26(5B):3877-83, 2006 - Who cited this? | PubMed ID: 17094417 | Fulltext

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

+ cite this

+ View Abstract

Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Blanke CD, Kerr D, Green E,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23(34):8664-70, 2005 Dec 1 - Who cited this? | PubMed ID: 16260700 | Fulltext

Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncology.

+ cite this

+ View Abstract

Bonnetain F, Bouché O, Conroy T, Arveux P, Raoul JL, Giovannini M, Etienne PL, Mitry E, Seitz JF, Rougier P, Girault C, Bedenne L, and FFCD (Fédération Francophone de Cancérologie Digestive)

Gastroenterologie clinique et biologique 29(11):1113-24, 2005 Nov - Who cited this? | PubMed ID: 16505756 | Fulltext

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801).

+ cite this

+ View Abstract

Bouché O, Ychou M, Burtin P, Bedenne L, Ducreux M, Lebreton G, Baulieux J, Nordlinger B, Martin C, Seitz JF, Tigaud JM, Echinard E, Stremsdoerfer N, Milan C, Rougier P, and Fédération Francophone de Cancérologie Digestive Group

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 16(9):1488-97, 2005 Sep - Who cited this? | PubMed ID: 15939717 | Fulltext

Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.

+ cite this

+ View Abstract

Nordlinger B, Rougier P, Arnaud JP, Debois M, Wils J, Ollier JC, Grobost O, Lasser P, Wals J, Lacourt J, Seitz JF, Guimares dos Santos J, Bleiberg H, Mackiewickz R, Conroy T, Bouché O,

(show remaining authors)

The lancet oncology 6(7):459-68, 2005 Jul - Who cited this? | PubMed ID: 15992694 | Fulltext

Capecitabine as adjuvant treatment for stage III colon cancer.

+ cite this

+ View Abstract

Twelves C, Wong A, Nowacki MP, Abt M, Burris H, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell D, Koralewski P, Kröning H, Maroun J, Marschner N,

(show remaining authors)

The New England journal of medicine 352(26):2696-704, 2005 Jun 30 - Who cited this? | PubMed ID: 15987918 | Fulltext

[Oxaliplatin neurotoxicity: a report of three cases with post-operative exacerbation].

+ cite this

+ View Abstract

Cournede A, Ries P, Richard K, Guillain A, Dahan L, Grandval P, Pourroy B, Moutardier V, Hardwigsen J, Braguer D, and Seitz JF

Gastroenterologie clinique et biologique 29(4):461-4, 2005 Apr - Who cited this? | PubMed ID: 15864213 | Fulltext

Postoperative chemoradiotherapy after surgical resection of gastric adenocarcinoma: can LV5FU2 reduce the toxic effects of the MacDonald regimen? A report on 23 patients.

+ cite this

+ View Abstract

Dahan L, Atlan D, Bouché O, Mitry E, Ries P, Artru P, Richard K, Lledo G, Nguyen T, Rougier P, and Seitz JF

Gastroenterologie clinique et biologique 29(1):11-5, 2005 Jan - Who cited this? | PubMed ID: 15738890 | Fulltext

Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.

+ cite this

+ View Abstract

Etienne MC, Formento JL, Chazal M, Francoual M, Magné N, Formento P, Bourgeon A, Seitz JF, Delpero JR, Letoublon C, Pezet D, and Milano G

Pharmacogenetics 14(12):785-92, 2004 Dec - Who cited this? | PubMed ID: 15608557 | Fulltext

Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803.

+ cite this

+ View Abstract

Bouché O, Raoul JL, Bonnetain F, Giovannini M, Etienne PL, Lledo G, Arsène D, Paitel JF, Guérin-Meyer V, Mitry E, Buecher B, Kaminsky MC, Seitz JF, Rougier P, Bedenne L, Milan C,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22(21):4319-28, 2004 Nov 1 - Who cited this? | PubMed ID: 15514373 | Fulltext

Pemetrexed in pancreatic cancer.

+ cite this

+ View Abstract

Seitz JF, Dahan L, and Ries P

Oncology (Williston Park, N.Y.) 18(13 Suppl 8):43-7, 2004 Nov - Who cited this? | PubMed ID: 15655936 | Fulltext

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients.

+ cite this

+ View Abstract

Ducreux M, Mitry E, Ould-Kaci M, Boige V, Seitz JF, Bugat R, Breau JL, Bouché O, Etienne PL, Tigaud JM, Morvan F, Cvitkovic E, and Rougier P

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 15(3):467-73, 2004 Mar - Who cited this? | PubMed ID: 14998850 | Fulltext

Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide.

+ cite this

+ View Abstract

Ruszniewski P, Ish-Shalom S, Wymenga M, O'Toole D, Arnold R, Tomassetti P, Bax N, Caplin M, Eriksson B, Glaser B, Ducreux M, Lombard-Bohas C, de Herder WW, Delle Fave G, Reed N, Seitz JF,

(show remaining authors)

Neuroendocrinology 80(4):244-51, 2004 - Who cited this? | PubMed ID: 15627802 | Fulltext

[Surgery for oesophageal cancer: current controversies].

+ cite this

+ View Abstract

Thomas P, Acri P, Doddoli C, D'journo B, Trousse D, Michelet P, Chetaille B, Papazian L, Giovannini M, Seitz JF, Giudicelli R, and Fuentes P

Annales de chirurgie 128(6):351-8, 2003 Jul - Who cited this? | PubMed ID: 12943829 | Fulltext

Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer.

+ cite this

+ View Abstract

Fallik D, Ychou M, Jacob J, Colin P, Seitz JF, Baulieux J, Adenis A, Douillard JY, Couzigou P, Mahjoubi R, Ducreux M, Mahjoubi M, and Rougier P

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 14(6):856-63, 2003 Jun - Who cited this? | PubMed ID: 12796022 | Fulltext

[Immunoallergic shock to oxaliplatin: a new case].

+ cite this

Cournède A, Ries P, Dahan L, Richard K, Grandval P, Braguer D, and Seitz JF

Gastroenterologie clinique et biologique 27(6-7):665-6, 2003 Jun - Who cited this? | PubMed ID: 12910238 | Fulltext

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors.

+ cite this

+ View Abstract

Ychou M, Conroy T, Seitz JF, Gourgou S, Hua A, Mery-Mignard D, and Kramar A

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 14(3):481-9, 2003 Mar - Who cited this? | PubMed ID: 12598357 | Fulltext

Search Google Scholar for Seitz JF

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!